Treatment of Leptomeningeal Disease with Tepotinib in a Patient with Lung Adenocarcinoma Harboring MET Exon 14 Skipping Mutation Presenting with Extensive Metastasis Involving Duodenum

<b>Background and Clinical Significance:</b> The mesenchymal–epithelial transition (MET) exon 14 skipping mutation (METex14) is a rare genetic alteration occurring in non-small cell lung cancer (NSCLC). Tyrosine kinase inhibitors (TKIs) are the approved treatment for first-line therapy in a metastat...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Jacquelyn Shugarts, Aida Amado, Taylor Praska, Monica Camou, Jiaxin Niu
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2025-06-01
Saila:	Reports
Gaiak:	METex14 subtype leptomeningeal duodenal metastases
Sarrera elektronikoa:	https://www.mdpi.com/2571-841X/8/2/96
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!